相关实验视频

Updated: Sep 11, 2025

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

在阿尔茨海默病中微质置换的理由和新出现的证据

Jee Yoon Bang¹, Yongjin Yoo²

¹Department of Neuroscience, Korea University College of Medicine, Seoul, Republic of Korea; Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA.

Molecules and cells

|August 16, 2025

概括

微质细胞在阿尔茨海默病 (AD) 中积极调节大脑健康. 新的研究探讨了针对这些细胞,包括干细胞衍生的微质细胞,作为AD的潜在治疗策略.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
遗传学是一个遗传学.

背景情况:

微质细胞曾经被认为是被动细胞,现在被认为是大脑平衡和突触重塑的活跃调节者.
微质与遗传风险因素和衰老的相互作用是阿尔茨海默病 (AD) 发病过程的核心.
了解微质的作用对于开发有效的AD疗法至关重要.

研究的目的:

总结一下了解微质对AD的贡献的最新进展.
探索微质细胞如何应对粉样蛋白-β和病理.
审查针对微质功能的新型治疗策略.

主要方法:

遗传学和转录学研究以确定AD中的微质作用.
对粉样β和病理学的微质反应的分析.
对新兴的微质替代疗法的审查.

主要成果:

微细胞在应对AD病理时采用不同的功能状态,具有取决于环境的保护性或有害作用.
遗传和转录基因数据突出显示了微质在阿尔茨海默病变发生过程中的中心作用.
在临床前的AD模型中,微质替代策略显示出前景.

结论:

微质是阿尔茨海默病的关键参与者,通过动态功能状态影响神经退行.
针对微质功能,特别是通过细胞替代疗法,为阿尔茨海默病和其他神经退行性疾病提供了一个有前途的新治疗途径.

关键词:

阿尔茨海默病的疾病阿尔茨海默病的疾病.细胞疗法是一种细胞疗法.微质细胞中的微质细胞微质细胞的替代体神经退行性疾病是一种神经退行性疾病.

更多相关视频

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

相关概念视频

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...